Friday, December 19, 2025
Friday, December 19, 2025

Starting people with opioid use disorder on extended-release, injectable naltrexone (XR-naltrexone) within five to seven days of seeking treatment is more effective than the standard treatment method of starting within 10-15 days, but requires closer medical supervision, according to results from a clinical trial. The findings suggest that this rapid treatment protocol could make XR-naltrexone more viable as a treatment option for opioid use disorder, which continues to take lives at an alarming rate.

An estimated 321,566 children in the United States lost a parent to drug overdose from 2011 to 2021, according to a new study. The rate of children who experienced this loss more than doubled during this period, from approximately 27 to 63 children per 100,000. The highest number of affected children were those with non-Hispanic white parents, but communities of color and tribal communities were disproportionately affected.

When breastfeeding mothers in a recent study used cannabis, its psychoactive component THC showed up in the milk they produced. The research also found that, unlike alcohol, when THC was detected in milk there was no consistent time when its concentration peaked and started to decline. Importantly, the researchers discovered that the amount of THC they detected in milk was low -- they estimated that infants received an average of 0.07 mg of THC per day. For comparison, a common low-dose edible contains 2 mg of THC. The research team stressed that it is unknown whether this amount has any impact on the infant.

More Articles …

  1. Gene linked to learning difficulties has direct impact on learning and memory
  2. Arizona’s now-repealed abortion ban serves as a cautionary tale for reproductive health care across the US
  3. AstraZeneca to withdraw Covid vaccine
  4. Mum never got over injecting son with infected blood
  5. Antisemitism complaints surge after Hamas attacks
  6. Antisemitism complaints by doctors surge
Page 1344 of 1936